NEPHROS, INC. Impairment of Intangible Assets (Excluding Goodwill)
NEPHROS, INC. (NEPH) reported Impairment of Intangible Assets (Excluding Goodwill) of $1.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2024-03-15
- NEPHROS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-12-31 was $0.00.
- NEPHROS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-09-30 was $1.00M.
- NEPHROS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2022 was $1.00M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.00M derived: sum of 2 quarters · filed 2024-03-15 | $1.00M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-08 | $1.00M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |